Dr Caroline J Small

Publications


Journals

  • White NE; Dhillo WS; Liu Y-L; Small CJ; Kennett GA; Gardiner JV; Ghatei MA; Bloom SR. (1 Feb 2008). Co-administration of SR141716 with peptide YY3-36 or oxyntomodulin has additive effects on food intake in mice. DIABETES OBESITY & METABOLISM. 10:167-170. Author weblink DOI.
  • Kuo YT; Parkinson JR; Chaudhri OB; Herlihy AH; So PW; Dhillo WS; Small CJ; Bloom SR; et alBell JD. (7 Nov 2007). The temporal sequence of gut peptide CNS interactions tracked in vivo by magnetic resonance imaging. J Neurosci. 27:12341-12348. DOI.
  • Martin NM; Small CJ; Lee JL; Ellis S; Dhillo WS; Smith KL; Kong WM; Frost GS; et alBloom SR. (May 2007). Low-dose oral tri-iodothyronine does not directly increase food intake in man. Diabetes Obes Metab. 9:435-437. DOI.
  • Jesudason DR; Monteiro MP; McGowan BM; Neary NM; Park AJ; Philippou E; Small CJ; Frost GS; et alGhatei MA; Bloom SR. (Mar 2007). Low-dose pancreatic polypeptide inhibits food intake in man. Br J Nutr. 97:426-429. DOI.
  • McGowan BM; Stanley SA; Smith KL; Minnion JS; Donovan J; Thompson EL; Patterson M; Connolly MM; et alAbbott CR; Small CJ; Gardiner JV; Ghatei MA; Bloom SR. (11 Sep 2006). Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept. 136:72-77. DOI Open Access copy.
  • Wynne K; Park AJ; Small CJ; Meeran K; Ghatei MA; Frost GS; Bloom SR. (Dec 2006). Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial. Int J Obes (Lond). 30:1729-1736. DOI.
  • Jethwa PH; Smith KL; Small CJ; Abbott CR; Darch SJ; Murphy KG; Seth A; Semjonous NM; et alPatel SR; Todd JF; Ghatei MA; Bloom SR. (Jun 2006). Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. Endocrinology. 147:2886-2892. DOI Open Access copy.
  • Murray JF; Hahn JD; Kennedy AR; Small CJ; Bloom SR; Haskell-Luevano C; Coen CW; Wilson CA. (1 Mar 2006). Evidence for a stimulatory action of melanin-concentrating hormone on luteinising hormone release involving MCH1 and melanocortin-5 receptors. JOURNAL OF NEUROENDOCRINOLOGY. 18:157-167. Author weblink DOI.
  • Martin NM; Smith KL; Bloom SR; Small CJ. (Feb 2006). Interactions between the melanocortin system and the hypothalamo-pituitary-thyroid axis. Peptides. 27:333-339. DOI Open Access copy.
  • Martin NM; Houston PA; Patterson M; Sajedi A; Carmignac DF; Ghatei MA; Bloom SR; Small CJ. (Mar 2006). Abnormalities of the somatotrophic axis in the obese agouti mouse. Int J Obes (Lond). 30:430-438. DOI.
  • Abbott CR; Small CJ; Sajedi A; Smith KL; Parkinson JR; Broadhead LL; Ghatei MA; Bloom SR. (Feb 2006). The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat. Int J Obes (Lond). 30:288-292. DOI.
  • Druce MR; Neary NM; Small CJ; Milton J; Monteiro M; Patterson M; Ghatei MA; Bloom SR. (Feb 2006). Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. Int J Obes (Lond). 30:293-296. DOI.
  • Neary NM; Druce MR; Small CJ; Bloom SR. (Jan 2006). Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut. 55:135.
  • Rossi M; Small CJ; Goldstone AP; Ghatei MA; Bloom SR. (1 Jun 1997). Melanin concentrating hormone (MCH) concentration is increased in the hypothalamus of obese Zucker rats. DIABETOLOGIA. 40:1054-1054. Author weblink.
  • Wynick D; Small CJ; Bacon A; Holmes FE; Norman M; Ormandy CJ; Kilic E; Kerr NCH; et alGhatei M; Talamantes F; Bloom SR; Pachnis V. (13 Oct 1998). Galanin regulates prolactin release and lactotroph proliferation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 95:12671-12676. Author weblink DOI.
  • Small CJ; Todd JF; Ghatei M; Smith DM; Bloom SR. (25 Sep 1998). Neuropeptide Y (NPY) actions on the corticotroph cell of the anterior pituitary gland are not mediated by a direct effect. REGULATORY PEPTIDES. 75-6:301-307. Author weblink DOI.
  • Small CJ; Bloom SR. (26 Nov 1998). Neuropharmacology - Cheap date. NATURE. 396:313-314. Author weblink DOI.
  • Small CJ; Goubillon ML; Murray JF; Siddiqui A; Grimshaw SE; Young H; Sivanesan V; Kalamatianos T; et alKennedy AR; Coen CW; Bloom SR; Wilson CA. (1 Jul 2003). Central orexin A has site-specific effects on luteinizing hormone release in female rats. ENDOCRINOLOGY. 144:3225-3236. Author weblink DOI.
  • Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; et alLow MJ; Ghatei MA; Cone RD; Bloom SR. (8 Jul 2004). Does gut hormone PYY3-36 decrease food intake in rodents? Reply. NATURE. 430. Author weblink DOI.
  • Small CJ; Carling D; Bloom SR. (1 Jul 2004). Cellular energy sensor balances the scales. NATURE MEDICINE. 10:681-682. Author weblink DOI.
  • Beak SA; Small CJ; Ilovaiskaia I; Hurley JD; Ghatei MA; Bloom SR; Smith DM. (Oct 1996). Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells. Endocrinology. 137:4130-4138.
  • O'Shea D; Morgan DG; Meeran K; Edwards CM; Turton MD; Choi SJ; Heath MM; Gunn I; et alTaylor GM; Howard JK; Bloom CI; Small CJ; Haddo O; Ma JJ; Callinan W; Smith DM; Ghatei MA; Bloom SR. (Jan 1997). Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology. 138:196-202.
  • Meeran K; O'Shea D; Upton PD; Small CJ; Ghatei MA; Byfield PH; Bloom SR. (Jan 1997). Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab. 82:95-100.
  • Small CJ; Morgan DG; Meeran K; Heath MM; Gunn I; Edwards CM; Gardiner J; Taylor GM; et alHurley JD; Rossi M; Goldstone AP; O'Shea D; Smith DM; Ghatei MA; Bloom SR. (14 Oct 1997). Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. Proc Natl Acad Sci U S A. 94:11686-11691.
  • Beak SA; Heath MM; Small CJ; Morgan DG; Ghatei MA; Taylor AD; Buckingham JC; Bloom SR; et alSmith DM. (15 Mar 1998). Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. J Clin Invest. 101:1334-1341. DOI.
  • Todd JF; Small CJ; Akinsanya KO; Stanley SA; Smith DM; Bloom SR. (Oct 1998). Galanin is a paracrine inhibitor of gonadotroph function in the female rat. Endocrinology. 139:4222-4229.
  • Rossi M; Kim MS; Morgan DG; Small CJ; Edwards CM; Sunter D; Abusnana S; Goldstone AP; et alRussell SH; Stanley SA; Smith DM; Yagaloff K; Ghatei MA; Bloom SR. (Oct 1998). A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology. 139:4428-4431.
  • Morgan DG; Small CJ; Abusnana S; Turton M; Gunn I; Heath M; Rossi M; Goldstone AP; et alO'Shea D; Meeran K; Ghatei M; Smith DM; Bloom S. (25 Sep 1998). The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism. Regul Pept. 75-76:377-382.
  • Meeran K; O'Shea D; Edwards CM; Turton MD; Heath MM; Gunn I; Abusnana S; Rossi M; et alSmall CJ; Goldstone AP; Taylor GM; Sunter D; Steere J; Choi SJ; Ghatei MA; Bloom SR. (Jan 1999). Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology. 140:244-250.
  • Stanley SA; Small CJ; Kim MS; Heath MM; Seal LJ; Russell SH; Ghatei MA; Bloom SR. (Nov 1999). Agouti related peptide (Agrp) stimulates the hypothalamo pituitary gonadal axis in vivo & in vitro in male rats. Endocrinology. 140:5459-5462.
  • Rossi M; Beak SA; Choi SJ; Small CJ; Morgan DG; Ghatei MA; Smith DM; Bloom SR. (6 Nov 1999). Investigation of the feeding effects of melanin concentrating hormone on food intake--action independent of galanin and the melanocortin receptors. Brain Res. 846:164-170.
  • Satoh F; Beak SA; Small CJ; Falzon M; Ghatei MA; Bloom SR; Smith DM. (Apr 2000). Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclase. Endocrinology. 141:1301-1309.
  • Kim MS; Small CJ; Stanley SA; Morgan DG; Seal LJ; Kong WM; Edwards CM; Abusnana S; et alSunter D; Ghatei MA; Bloom SR. (Apr 2000). The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest. 105:1005-1011. DOI.
  • Seal LJ; Small CJ; Kim MS; Stanley SA; Taheri S; Ghatei MA; Bloom SR. (May 2000). Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male rats. Endocrinology. 141:1909-1912.
  • Kim MS; Rossi M; Abusnana S; Sunter D; Morgan DG; Small CJ; Edwards CM; Heath MM; et alStanley SA; Seal LJ; Bhatti JR; Smith DM; Ghatei MA; Bloom SR. (Feb 2000). Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes. 49:177-182.
  • Abbott CR; Monteiro M; Small CJ; Sajedi A; Smith KL; Parkinson JR; Ghatei MA; Bloom SR. (17 May 2005). The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 1044:127-131. DOI.
  • Wynne K; Giannitsopoulou K; Small CJ; Patterson M; Frost G; Ghatei MA; Brown EA; Bloom SR; et alChoi P. (Jul 2005). Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol. 16:2111-2118. DOI.
  • Small CJ; Parkinson JR; Bloom SR. (Apr 2005). Novel therapeutic targets for appetite regulation. Curr Opin Investig Drugs. 6:369-372.
  • le Roux CW; Neary NM; Halsey TJ; Small CJ; Martinez-Isla AM; Ghatei MA; Theodorou NA; Bloom SR. (Aug 2005). Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab. 90:4521-4524. DOI.
  • Small CJ; Bloom SR. (May 2005). The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity. Expert Opin Investig Drugs. 14:647-653. DOI.
  • Jethwa PH; Small CJ; Smith KL; Seth A; Darch SJ; Abbott CR; Murphy KG; Todd JF; et alGhatei MA; Bloom SR. (Aug 2005). Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. Am J Physiol Endocrinol Metab. 289:E301-E305. DOI.
  • Wynne K; Park AJ; Small CJ; Patterson M; Ellis SM; Murphy KG; Wren AM; Frost GS; et alMeeran K; Ghatei MA; Bloom SR. (Aug 2005). Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes. 54:2390-2395.
  • Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; et alWang F; Kent AS; Frost GS; Ghatei MA; Bloom SR. (Dec 2005). Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology. 146:5120-5127. DOI.
  • Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR. (10 May 2005). Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res. 1043:139-144. DOI.
  • Andersson U; Treebak JT; Nielsen JN; Smith KL; Abbott CR; Small CJ; Carling D; Richter EA. (8 Apr 2005). Exercise in rats does not alter hypothalamic AMP-activated protein kinase activity. Biochem Biophys Res Commun. 329:719-725. DOI Open Access copy.
  • Martin NM; Small CJ; Sajedi A; Liao XH; Weiss RE; Gardiner JV; Ghatei MA; Bloom SR. (15 Nov 2004). Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouse. Regul Pept. 122:169-172. DOI.
  • Kong WM; Martin NM; Smith KL; Gardiner JV; Connoley IP; Stephens DA; Dhillo WS; Ghatei MA; et alSmall CJ; Bloom SR. (Nov 2004). Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. Endocrinology. 145:5252-5258. DOI Open Access copy.
  • Thompson EL; Murphy KG; Todd JF; Martin NM; Small CJ; Ghatei MA; Bloom SR. (8 Oct 2004). Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. Biochem Biophys Res Commun. 323:65-71. DOI.
  • Small CJ; Bloom SR. (Oct 2004). Gut hormones as peripheral anti obesity targets. Curr Drug Targets CNS Neurol Disord. 3:379-388.
  • Stanley SA; Murphy KG; Bewick GA; Kong WM; Opacka-Juffry J; Gardiner JV; Ghatei M; Small CJ; et alBloom SR. (Sep 2004). Regulation of rat pituitary cocaine- and amphetamine-regulated transcript (CART) by CRH and glucocorticoids. Am J Physiol Endocrinol Metab. 287:E583-E590. DOI.
  • Small CJ; Bloom SR. (Aug 2004). Gut hormones and the control of appetite. Trends Endocrinol Metab. 15:259-263. DOI.
  • Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR. (Jul 2004). Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin. Int J Obes Relat Metab Disord. 28:886-893. DOI.
  • Druce MR; Small CJ; Bloom SR. (Jun 2004). Minireview: Gut peptides regulating satiety. Endocrinology. 145:2660-2665. DOI.
  • Neary NM; Small CJ; Wren AM; Lee JL; Druce MR; Palmieri C; Frost GS; Ghatei MA; et alCoombes RC; Bloom SR. (Jun 2004). Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 89:2832-2836. DOI.
  • Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR. (Jun 2004). Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology. 145:2687-2695. DOI.
  • Andersson U; Filipsson K; Abbott CR; Woods A; Smith K; Bloom SR; Carling D; Small CJ. (26 Mar 2004). AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem. 279:12005-12008. DOI Open Access copy.
  • Abbott CR; Kennedy AR; Wren AM; Rossi M; Murphy KG; Seal LJ; Todd JF; Ghatei MA; et alSmall CJ; Bloom SR. (Sep 2003). Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology. 144:3943-3949.
  • Neary NM; Small CJ; Bloom SR. (Jul 2003). Gut and mind. Gut. 52:918-921.
  • Stanley SA; Davies S; Small CJ; Gardiner JV; Ghatei MA; Smith DM; Bloom SR. (22 May 2003). gamma-MSH increases intracellular cAMP accumulation and GnRH release in vitro and LH release in vivo. FEBS Lett. 543:66-70.
  • Small CJ; Liu YL; Stanley SA; Connoley IP; Kennedy A; Stock MJ; Bloom SR. (Apr 2003). Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure. Int J Obes Relat Metab Disord. 27:530-533. DOI.
  • Dhillo WS; Small CJ; Jethwa PH; Russell SH; Gardiner JV; Bewick GA; Seth A; Murphy KG; et alGhatei MA; Bloom SR. (Apr 2003). Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary-adrenal axis. Endocrinology. 144:1420-1425.
  • Dhillo WS; Small CJ; Gardiner JV; Bewick GA; Whitworth EJ; Jethwa PH; Seal LJ; Ghatei MA; et alHinson JP; Bloom SR. (31 Jan 2003). Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland. Biochem Biophys Res Commun. 301:102-107.
  • Dakin CL; Small CJ; Park AJ; Seth A; Ghatei MA; Bloom SR. (Dec 2002). Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats. Am J Physiol Endocrinol Metab. 283:E1173-E1177. DOI.
  • Bacon A; Holmes FE; Small CJ; Ghatei M; Mahoney S; Bloom S; Wynick D. (15 Nov 2002). Transgenic over-expression of galanin in injured primary sensory neurons. Neuroreport. 13:2129-2132.
  • Small CJ; Stanley SA; Bloom SR. (Nov 2002). Appetite control and reproduction: leptin and beyond. Semin Reprod Med. 20:389-398. DOI.
  • Wren AM; Small CJ; Abbott CR; Jethwa PH; Kennedy AR; Murphy KG; Stanley SA; Zollner AN; et alGhatei MA; Bloom SR. (Nov 2002). Hypothalamic actions of neuromedin U. Endocrinology. 143:4227-4234. Open Access copy.
  • Wren AM; Small CJ; Fribbens CV; Neary NM; Ward HL; Seal LJ; Ghatei MA; Bloom SR. (Nov 2002). The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology. 76:316-324.
  • Dhillo WS; Small CJ; Stanley SA; Jethwa PH; Seal LJ; Murphy KG; Ghatei MA; Bloom SR. (Sep 2002). Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocyte-stimulating hormone in vitro in male rats. J Neuroendocrinol. 14:725-730.
  • Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; et alLow MJ; Ghatei MA; Cone RD; Bloom SR. (8 Aug 2002). Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 418:650-654. DOI.
  • Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR. (Aug 2002). Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus. Neuroendocrinology. 76:70-78.
  • Dhillo WS; Small CJ; Seal LJ; Kim MS; Stanley SA; Murphy KG; Ghatei MA; Bloom SR. (Apr 2002). The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats. Neuroendocrinology. 75:209-216.
  • Kim MS; Small CJ; Russell SH; Morgan DG; Abbott CR; alAhmed SH; Hay DL; Ghatei MA; et alSmith DM; Bloom SR. (Apr 2002). Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors. J Neuroendocrinol. 14:276-282.
  • Russell SH; Small CJ; Sunter D; Morgan I; Dakin CL; Cohen MA; Bloom SR. (15 Mar 2002). Chronic intraparaventricular nuclear administration of orexin A in male rats does not alter thyroid axis or uncoupling protein-1 in brown adipose tissue. Regul Pept. 104:61-68.
  • Russell SH; Small CJ; Kennedy AR; Stanley SA; Seth A; Murphy KG; Taheri S; Ghatei MA; et alBloom SR. (Dec 2001). Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology. 142:5294-5302.
  • Wren AM; Small CJ; Abbott CR; Dhillo WS; Seal LJ; Cohen MA; Batterham RL; Taheri S; et alStanley SA; Ghatei MA; Bloom SR. (Nov 2001). Ghrelin causes hyperphagia and obesity in rats. Diabetes. 50:2540-2547. Open Access copy.
  • Seal LJ; Small CJ; Dhillo WS; Stanley SA; Abbott CR; Ghatei MA; Bloom SR. (Oct 2001). PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. Endocrinology. 142:4236-4243.
  • Dakin CL; Gunn I; Small CJ; Edwards CM; Hay DL; Smith DM; Ghatei MA; Bloom SR. (Oct 2001). Oxyntomodulin inhibits food intake in the rat. Endocrinology. 142:4244-4250.
  • Ward HL; Small CJ; Murphy KG; Kennedy AR; Ghatei MA; Bloom SR. (Aug 2001). The actions of tuberoinfundibular peptide on the hypothalamo-pituitary axes. Endocrinology. 142:3451-3456.
  • Abbott CR; Rossi M; Wren AM; Murphy KG; Kennedy AR; Stanley SA; Zollner AN; Morgan DG; et alMorgan I; Ghatei MA; Small CJ; Bloom SR. (Aug 2001). Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology. 142:3457-3463.
  • Kennedy AR; Todd JF; Stanley SA; Abbott CR; Small CJ; Ghatei MA; Bloom SR. (Jul 2001). Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary. Endocrinology. 142:3265-3268.
  • Russell SH; Small CJ; Dakin CL; Abbott CR; Morgan DG; Ghatei MA; Bloom SR. (Jun 2001). The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol. 13:561-566.
  • Taheri S; Gardiner J; Hafizi S; Murphy K; Dakin C; Seal L; Small C; Ghatei M; et alBloom S. (5 Mar 2001). Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats. Neuroreport. 12:459-464.
  • Stanley SA; Small CJ; Murphy KG; Rayes E; Abbott CR; Seal LJ; Morgan DG; Sunter D; et alDakin CL; Kim MS; Hunter R; Kuhar M; Ghatei MA; Bloom SR. (2 Mar 2001). Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res. 893:186-194.
  • Russell SH; Small CJ; Stanley SA; Franks S; Ghatei MA; Bloom SR. (Mar 2001). The in vitro role of tumour necrosis factor-alpha and interleukin-6 in the hypothalamic-pituitary gonadal axis. J Neuroendocrinol. 13:296-301.
  • Small CJ; Kim MS; Stanley SA; Mitchell JR; Murphy K; Morgan DG; Ghatei MA; Bloom SR. (Feb 2001). Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes. 50:248-254.
  • Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; et alGhatei MA; Bloom SR. (Dec 2000). Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. J Neuroendocrinol. 12:1213-1218.
  • Wren AM; Small CJ; Ward HL; Murphy KG; Dakin CL; Taheri S; Kennedy AR; Roberts GH; et alMorgan DG; Ghatei MA; Bloom SR. (Nov 2000). The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 141:4325-4328.
  • Stanley SA; Todd JF; Small CJ; Kim MS; Heath MM; Anand P; Ghatei MA; Bloom SR. (Oct 2000). The effects of ciliary neurotrophic factor on the hypothalamo-pituitary gonadal axis in vitro in female rats. J Neuroendocrinol. 12:1009-1013.

Conferences

  • Wynick D; Small CJ; Bloom SR; Pachnis V. Targeted disruption of the murine galanin gene. Conference on Galanin - Basic Research Discoveries and Therapeutic Implications. 863:22-47. (1998).
  • Small CJ; Rossi M; Bloom SR. Glucagon like peptide-1 (GLP-1), Neuropeptide Y (NPY) and Melanin Concentrating Hormone (MCH) in the hypothalamic regulation of food intake. 8th International Congress on Obesity. 279-288. (1999).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook